Emeritus Professor of Medicine
Gastroenterology
Dr. Douglas R. Labrecque, MD
|
|
Give Review
Douglas R. Labrecque practices Gastroenterology. He went to Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Douglas Labrecque is a published doctor as well. He has 74 publications published. The latest was: Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. He accepts all Medicare patients.
Publications
- World gastroenterology organisation global guidelines: nonalcoholic Fatty liver disease and nonalcoholic steatohepatitis.
- Predicting cancer mortality: developing a new cancer care variable using mixed methods and the quasi-statistical approach.
- Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
- Progressive multifocal leukoencephalopathy with peripheral demyelinating neuropathy in a liver transplant patient.
- Treatment of hepatitis C cryoglobulinemia: mission and challenges.
- GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
- Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein.
- A large biloma causing gastric outlet obstruction after a percutaneous liver biopsy.
- T-cell activation after chronic ethanol ingestion in mice.
- Hepatitis C virus-infected patients report communication problems with physicians.
- Liver transplantation for disulfiram-induced fulminant hepatic failure.
- "They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C.
- Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
- Heritable urea cycle enzyme deficiency-liver disease in 16 patients.
- The role of hepatotrophic factors in liver regeneration--a brief review including a preliminary report of the in vitro effects of hepatic regenerative stimulator subst...
- The reliability of alcoholism history in patients with alcohol-related cirrhosis.
- Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.
- The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature.
- Transplantation of patients with alcoholic liver disease.
- Personality disorder as a contraindication for liver transplantation in alcoholic cirrhosis.
- Hepatocyte growth factor--how do I know thee? Let me count the ways.
- In vitro stimulation of cell growth by hepatic stimulator substance.
- Serial bilirubin determinations as a prognostic marker in clinical infections.
- Hemosiderosis without cirrhosis: an unusual case of portal hypertension.
- Liver ultrastructure in mitochondrial urea cycle enzyme deficiencies and comparison with Reye's syndrome.
- The risk of hepatitis B transmission from staff to patients in hemodialysis units--an overrated problem?
- Purification and physical-chemical characterization of hepatic stimulator substance.
- The risk of hepatitis B transmission from health care workers to patients in a hospital setting--a prospective study.
- Hepatic stimulator substance. Discovery, characteristics and mechanism of action.
- Cholesterol metabolism in regenerating liver of the rat.
- Ophthalmic features of Alagille syndrome (arteriohepatic dysplasia).
- Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver.
- Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance.
- Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease.
- Omeprazole heals mucosal ulcers associated with endoscopic injection sclerotherapy.
- Pyloric stenosis and direct hyperbilirubinemia with alpha-1-antitrypsin deficiency.
- Severe hepatic damage after acetaminophen use in psittacosis.
- The evolving nature of "infantile obstructive cholangiopathy".
- Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoim...
- A commonsense approach to variceal bleeding.
- Medical ostriches.
- Corset liver.
- Effect of chronic ethanol ingestion on hepatic and intestinal acyl coenzyme a:cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme a reductase in the rat.
- Mitogenic effects of hepatic stimulator substance on cultured nonparenchymal liver epithelial cells.
- Successful treatment of hepatic venocclusive disease in a bone marrow transplant patient with side-to-side portacaval shunt.
- Lipogranulomas and gold in the liver in rheumatoid arthritis.
- Liver regeneration: a picture emerges from the puzzle.
- A model to examine the validity of the 6-month abstinence criterion for liver transplantation.
- Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics.
- A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.
- Four generations of arteriohepatic dysplasia.
- Modulation of T-cell adhesion markers, and the CD45R and CD57 antigens in human alcoholics.
- Suprahepatic venacavaplasty (cavaplasty) with retrohepatic cava extension in liver transplantation: experience with first 115 cases.
- Ethanol and natural killer cells. I. Activity and immunophenotype in alcoholic humans.
- Visualization and characterization of GB virus-C particles: evidence for a nucleocapsid.
- TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease.
- Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.
- Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
- Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.
- Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.
- Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein.
- Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load.
- Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells.
- Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology.
- Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.
- Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.
- Liver regeneration investigated in a non-human primate model (Macaca mulatta).
- World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.
- Hepatocellular carcinoma (HCC): a global perspective.
- Calcite precipitation dominates the electrical signatures of zero valent iron columns under simulated field conditions.
- A comparison of the low frequency electrical signatures of iron oxide versus calcite precipitation in granular zero valent iron columns.
- Mental and physical symptoms associated with lower social support for patients with hepatitis C.
- Majority of patients with hepatitis C express physical, mental, and social difficulties with antiviral treatment.
Schools
Stanford University School Of Medicine
Duke University Med Center
National Cancer Institute
Yale New Haven
Doctors Specialties
- Internal Medicine
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Duke University Hospital -
Stanford University School of Medicine
Drug Facts
| NPI NUMBER | 1063489953 | |
| NPPES Provider LastName | LABRECQUE | |
| NPPES Provider FirstName | DOUGLAS | |
| NPPES Provider ZIPCode | 522421009 | |
| NPPES Provider State | IA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 378.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063489953 |
| Last Name Of The Provider | LABRECQUE |
| First Name Of The Provider | DOUGLAS |
| View All |
Similar Doctors
|
|
Dr. Thomas A. Brown, MD |
|
|
Dr. Tariq Hameed, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali Dahhan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Buatti, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hossam E. Mustafa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin K. Spengler, MD |
|
|
Dr. Alexis I. Wickersham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Goerdt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberly S. Delcour, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine Cho, MD |
|
|
Dr. Joseph A. Truszkowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohan Khera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven F. Polyak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick M. Noonan, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle E. Brown, MD
This Doctor is OpenDoctor Recommended.
|